P3 Health Partners Inc - Class A PIII Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$4.00 up $0.18, 4.71% at close Nov 6
Last close · Previous close $3.82
- Market cap
- At the Nov 6 close
- P/E ratio
- PausedOn last 12 months’ EPS
See the note under the price. - Diluted EPS
- PausedLast 12 months
See the note under the price. - Dividend yield
- NoneLast 12 months
Price chart
$4.00down $1.62, 28.83%Past month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$3.82Nov 5
- Volume7.33KNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume16.54KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $1.52 to $16.89; now $4.00
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
PIII beat the S&P 500 in 1 of 6 periods.
| Period | PIII and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | PIII: down 28.8% S&P 500: down 5.6% | PIII trailed the S&P 500 by 23.2 percentage points Trailed |
| 3M | PIII: down 63.3% S&P 500: down 4.1% | PIII trailed the S&P 500 by 59.2 percentage points Trailed |
| YTD | PIII: up 14.6% S&P 500: up 8.7% | PIII beat the S&P 500 by 5.9 percentage points Beat |
| 1Y | PIII: down 50.2% S&P 500: up 10.9% | PIII trailed the S&P 500 by 61.1 percentage points Trailed |
| Long term | ||
| 3Y | PIII: down 94.8% S&P 500: up 75.0% −62.6% vs +20.5% a year | PIII trailed the S&P 500 by 169.8 percentage points Trailed |
| 5Y | PIII: down 99.2% S&P 500: up 67.8% −61.9% vs +10.9% a year | PIII trailed the S&P 500 by 167.0 percentage points Trailed |
$10,000 invested in PIII 5 years ago (Nov 5, 2021) would be worth about $80 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $16,782.
PIII beat the S&P 500 in 1 of 6 periods.
| Period | PIII and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | PIII: down 28.8% S&P 500: down 5.6% | PIII trailed the S&P 500 by 23.2 percentage points Trailed |
| 3M | PIII: down 63.3% S&P 500: down 4.3% | PIII trailed the S&P 500 by 59.0 percentage points Trailed |
| YTD | PIII: up 14.6% S&P 500: up 7.8% | PIII beat the S&P 500 by 6.8 percentage points Beat |
| 1Y | PIII: down 50.2% S&P 500: up 9.7% | PIII trailed the S&P 500 by 59.9 percentage points Trailed |
| Long term | ||
| 3Y | PIII: down 94.8% S&P 500: up 68.8% −62.6% vs +19.1% a year | PIII trailed the S&P 500 by 163.6 percentage points Trailed |
| 5Y | PIII: down 99.2% S&P 500: up 56.9% −61.9% vs +9.4% a year | PIII trailed the S&P 500 by 156.1 percentage points Trailed |
$10,000 invested in PIII 5 years ago (Nov 5, 2021) would be worth about $80 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $15,694.
All-time high
$572.00
Closing high on . Now 99.3% below that record.
Split-adjusted daily closes since Apr 6, 2021.
Stock splits
1
1-for-50 on . Share counts adjust after each split.
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $1.50Bup 2.8%
- Net income
- −$98.44M
- Diluted EPS
- PausedSee the note under the price.
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q3 FY24 (Sep 30, 2024) | $362.12M | −$46.51M | Paused See the note under the price. |
| Q4 FY24 (Dec 31, 2024) | $370.69M | −$58.62M | Paused See the note under the price. |
| Q1 FY25 (Mar 31, 2025) | $373.23M | −$20.48M | Paused See the note under the price. |
| Q2 FY25 (Jun 30, 2025) | $355.79M | −$20.36M | Paused See the note under the price. |
| Q3 FY25 (Sep 30, 2025) | $345.25M | −$31.59M | Paused See the note under the price. |
| Q4 FY25 (Dec 31, 2025) | $384.81M | −$75.52M | Paused See the note under the price. |
| Q1 FY26 (Mar 31, 2026) | $386.39M | $1.22M | Paused See the note under the price. |
| Q2 FY26 (Jun 30, 2026) | $386.38M | $7.44M | Paused See the note under the price. |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY20 (Dec 31, 2020) | $485.54M | −$41.07M | Paused See the note under the price. |
| FY22 (Dec 31, 2022) | $1.05B | −$270.13M | Paused See the note under the price. |
| FY23 (Dec 31, 2023) | $1.27B | −$57.77M | Paused See the note under the price. |
| FY24 (Dec 31, 2024) | $1.50B | −$135.85M | Paused See the note under the price. |
| FY25 (Dec 31, 2025) | $1.46B | −$147.95M | Paused See the note under the price. |
Margins
- Gross 3.5%
- Operating −9.9%
- Net −6.6%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- −$130.44MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow−$130.52MLast 12 months
- Capital spending$79.00KLast 12 months
- −8.7%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $15.96MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$0.00Last 12 months
Balance sheet
- $22.19MAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$130.69MAs of Jun 30, 2026
- Net debt$108.50MAs of Jun 30, 2026
- Book value per sharePausedAs of Jun 30, 2026
See the note under the price. - 0.46As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 1.81As of Jun 30, 2026
Total debt divided by shareholders’ equity on the Jun 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 4 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✗Net income was positive: not passed
- ✗Operating cash flow was positive: not passed
- ✓Return on assets improved: passed
- ✗Operating cash flow exceeded net income: not passed
- ✗Long-term debt fell relative to assets: not passed
- ✓Current ratio improved: passed
- ✗Share count didn’t rise: not passed
- ✓Gross margin improved: passed
- ✓Asset turnover (revenue ÷ assets) improved: passed
- −14.8%Last 12 months
Over the last 12 months, P3 Health Partners’s net loss was 14.8% of its total assets (averaged over the last four quarter-ends).
ROA = Net income (last 12 months) ÷ Average total assets
About P3 Health Partners Inc - Class A
Foresight Acquisition Corp - Class A
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Illinois, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
PIII news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
PIII stock FAQ
What is PIII stock’s price today?
P3 Health Partners (PIII) traded at $4.00 at the close on , up $0.18 (4.71%) from the previous close of $3.82. Over the past 52 weeks it has traded between $1.52 and $16.89.
If you invested $1,000 in PIII 5 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in PIII on would be worth about $8 at the close on , a total return of −99.2%. The same $1,000 would be worth $498 if invested one year ago. Past performance doesn’t predict future returns.
How much revenue does P3 Health Partners make?
P3 Health Partners reported $1.5 billion of revenue over the four quarters to , up 2.8% from the twelve months before. In its latest quarter (Q2 FY26, ended ) revenue was $386.4 million, up 8.6% from a year earlier.
Is P3 Health Partners profitable?
Not over the four quarters to . P3 Health Partners reported a net loss of $98.4 million across those four quarters on $1.5 billion of revenue.
Does PIII pay a dividend?
P3 Health Partners hasn’t paid a dividend in the last twelve months.
What is PIII’s 52-week high and low?
Over the past 52 weeks PIII has traded as low as $1.52 and as high as $16.89. At $4.00 at the close on , it is 76.3% below that high and 163.2% above the low.
What is PIII’s all-time high?
PIII’s highest closing price was $572.00 on , adjusted for stock splits. At $4.00 at the close on , it is 99.3% below that record.
Has PIII stock ever split?
Yes, once: 1-for-50 on .
How has PIII stock performed?
Including dividends and measured to the close on , PIII has returned +14.6% so far this year and −50.2% over the past year, and −99.2% over five years (−61.9% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is P3 Health Partners in?
P3 Health Partners is in the Healthcare sector and the Medical Care Facilities industry, and is headquartered in Illinois, USA.
What exchange does PIII trade on?
P3 Health Partners trades on the Nasdaq under the ticker symbol PIII. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.